Why you should get the COVID-19 booster.
Within the past week, COVID-19 infections are at a record high due to the spread of Omicron and Delta strains. Since only a quarter of the U.S. population has received the COVID-19 booster, here is why you should get the booster.
Regardless if you were previously infected with COVID-19 and/or received both doses of the vaccine, you should still get the booster given recent data published by the CDC. One example exhibiting the need for a booster is a family in Nebraska who contracted COVID-19. This family still contracted Omicron despite having previous COVID-19 infections or being vaccinated (1).
Current data reveals stark differences in COVID-19 infection outcomes when comparing those who received the booster to those who didn’t. Research in Israel demonstrated that those who received a third COVID-19 vaccine had a 70-84% reduction in COVID-19 infection rates (2). Another study in Israel revealed that the third dose was 92% more effective in preventing severe illnesses compared to individuals that had two vaccination doses five months prior (2). They also witnessed a 90% decrease in mortality in patients who had the booster (2). The New England Journal of Medicine also confirmed these findings when analyzing the Israel Health database of over 4 million individuals; those with the booster shot were much less likely to contract COVID-19 and had lower rates of severe illness and death (3).
Overall, the data exhibits the great importance of obtaining the COVID-19 booster regardless if you’ve had previous doses of the vaccine and/or were infected. It is saving lives, reducing symptoms, and preventing severe illness. Please consider getting one if you have not already to protect yourself, your family, and the general public.
- Jansen L, Tegomoh B, Lange K, et al. Investigation of a SARS-CoV-2 B.1.1.529 (Omicron) Variant Cluster — Nebraska, November–December 2021. MMWR Morb Mortal Wkly Rep. ePub: 28 December 2021. DOI: http://dx.doi.org/10.15585/mmwr.mm705152e3external icon
- Barda N, Dagan N, Cohen C, Hernán MA, Lipsitch M, Kohane IS, Reis BY, Balicer RD. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study. Lancet. 2021 Dec 4;398(10316):2093-2100. doi: 10.1016/S0140-6736(21)02249-2. Epub 2021 Oct 29. PMID: 34756184; PMCID: PMC8555967.
- Bar-On YM, Goldberg Y, Mandel M, Bodenheimer O, Freedman L, Alroy-Preis S, Ash N, Huppert A, Milo R. Protection against Covid-19 by BNT162b2 Booster across Age Groups. N Engl J Med. 2021 Dec 23;385(26):2421-2430. doi: 10.1056/NEJMoa2115926. Epub 2021 Dec 8. PMID: 34879188.
2800 Shirlington Road Suite 100
Arlington VA 22206
Phone: (703) 844-7770
Fax : 703-866-3133